Renal transplantation in patients with human T-cell lymphotropic virus type 1.
暂无分享,去创建一个
Y. Tomita | S. Fuchinoue | K. Iwadoh | I. Nakajima | I. Koyama | H. Shirai | K. Kai | M. Suzuki | A. Sannomiya
[1] S. Belknap,et al. Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] M. Kannagi. Immunologic Control of Human T-Cell Leukemia Virus Type I and Adult T-Cell Leukemia , 2007, International journal of hematology.
[3] E. Murphy,et al. Global epidemiology of HTLV-I infection and associated diseases , 2005, Oncogene.
[4] K. Ohshima,et al. Prognosis of HTLV-I-positive renal transplant recipients. , 2005, Transplantation proceedings.
[5] Mitsuhiro Osame,et al. Spread of HTLV-I Between Lymphocytes by Virus-Induced Polarization of the Cytoskeleton , 2003, Science.
[6] M. Tomonaga,et al. A new G‐CSF‐supported combination chemotherapy, LSG15, for adult T‐cell leukaemia‐lymphoma: Japan Clinical Oncology Group Study 9303 , 2001, British journal of haematology.
[7] Y. Kodera,et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation , 2001, Bone Marrow Transplantation.
[8] J. D. van der Walt,et al. Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma during immunosuppressive treatment following renal transplantation. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.